Skip to main content
OpenTrials

Clinical trial condition

Albinism

Explore clinical trials studying Albinism. Study availability and eligibility vary by location and protocol.

37 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Albinism trial results

Completed

Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study

NCT01735955

Conditions
Acute Lymphoblastic Leukemia (ALL), Albinism, Amino Acid Metabolism, Inborn Errors, +41 more
Locations
  • Novartis Investigative Site Albany, New York, United States
  • Novartis Investigative Site Houston, Texas, United States
  • Novartis Investigative Site Vienna, Austria
  • Novartis Investigative Site Vancouver, British Columbia, Canada
View all 33 locations
View Trial Details
Completed

A Longitudinal Study of Hermansky-Pudlak Syndrome Pulmonary Fibrosis

NCT02368340

Conditions
Albinism, Albinism, Oculocutaneous, Amino Acid Metabolism, Inborn Errors, +21 more
Locations
  • Loyola University Medical Center Maywood, Illinois, United States
  • Brigham and Women's Hospital, Harvard Boston, Massachusetts, United States
  • Columbia University Medical Center New York, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis

NCT00814073

Conditions
Albinism, Amino Acid Metabolism, Inborn Errors, Behavior, +28 more
Locations
  • UC Davis Health System , Department of Dermatology Sacramento, California, United States
  • MD Anderson Cancer Centre Houston, Texas, United States
  • CHU d'Amiens Amiens, France
  • Hôpital Avicenne Bobigny, France
View all 24 locations
View Trial Details
Completed

Evaluation of Non-cultured Epidermal Cellular Grafting vs Hyaluronic Acid for Repigmenting Vitiligo and Piebaldism

NCT02156427

Conditions
Albinism, Amino Acid Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
Locations
  • Department of Dermatology - Ghent University Hospital Ghent, Belgium
  • University Hospital Center of Bordeaux Bordeaux, France
  • CHU Le Mans Le Mans, France
  • Dr Michel PASCAL Paris, France
View Trial Details

Related conditions